홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.0
  1. 홈
  2. /반응

Dichloromethane → HCID 67995855, 화합물

HRID 1467316
노트
인쇄 미리보기

반응식

HRID 1467316 반응식
[F:1][C:2]1[CH:23]=[CH:22][CH:21]=[C:20]([O:24][CH3:25])[C:3]=1[CH2:4][N:5]1[CH2:10][CH2:9][CH2:8][CH:7]([NH:11]C(=O)OC(C)(C)C)[C:6]1=[O:19].ClCCl.FC(F)(F)C(O)=O>C1(C)C=CC=CC=1>[NH2:11][CH:7]1[CH2:8][CH2:9][CH2:10][N:5]([CH2:4][C:3]2[C:20]([O:24][CH3:25])=[CH:21][CH:22]=[CH:23][C:2]=2[F:1])[C:6]1=[O:19]
참가 물질실험 절차후처리출처 및 근거반응 노트

참가 물질

5

반응물 3

HCID 6344DichloromethaneHCID 6422Trifluoroacetic acidHCID 86681278HCID 86681278, 화합물

생성물 1

HCID 67995855HCID 67995855, 화합물

시약·촉매·용매 1

HCID 1140Toluene용매

실험 절차

The synthetic intermediate from Step 1 (329 mg, 0.934 mmol), dichloromethane (1 ml), and trifluoroacetic acid (1 ml) were combined in an open vial, and the mixture was allowed to stir for 1 hour. The mixture was then diluted with toluene (3 ml) and subsequently concentrated to dryness. Crude (3-amino-1-(2-fluoro-6-methoxybenzyl)piperidin-2-one so obtained was used in the next synthetic transformation without additional purification.

이 페이지에서참가 물질실험 절차후처리출처 및 근거반응 노트

후처리

  1. concentrationsubsequently concentrated to dryness

출처 및 근거

ORD 기록
ord-e02035e5b827476ca9cb5fd49393e430
출처 데이터셋
uspto-grants-2015_04
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US08999957B2

반응 노트

불러오는 중…